The impact of the COVID-19 pandemic on cancer care.
Mike RichardsMichael AndersonPaul CarterBenjamin L EbertElias MossialosPublished in: Nature cancer (2020)
The COVID-19 pandemic has disrupted the spectrum of cancer care, including delaying diagnoses and treatment and halting clinical trials. In response, healthcare systems are rapidly reorganizing cancer services to ensure that patients continue to receive essential care while minimizing exposure to SARS-CoV-2 infection.
Keyphrases
- healthcare
- clinical trial
- ejection fraction
- newly diagnosed
- primary care
- palliative care
- prognostic factors
- papillary thyroid
- mental health
- randomized controlled trial
- affordable care act
- quality improvement
- pain management
- chronic kidney disease
- respiratory syndrome coronavirus
- health information
- chronic pain
- smoking cessation